High-Bleeding Risk Procedures Requiring Aspirin Discontinuation
For high-bleeding risk procedures, aspirin should be discontinued 5 days preoperatively to ensure complete correction of platelet function in all patients, with neurosurgery being the prototypical example of such procedures. 1
Definition of High-Bleeding Risk Procedures
High-bleeding risk procedures are those where incomplete correction of aspirin-induced platelet dysfunction could result in catastrophic bleeding with significant morbidity or mortality. The key characteristic is that bleeding in these anatomical locations cannot be easily controlled or compressed. 1
Specific High-Risk Procedures Requiring 5-Day Aspirin Washout:
- Neurosurgery (intracranial procedures) - explicitly cited as requiring 5-day washout 1
- Closed-space surgery where bleeding cannot be easily identified or controlled 2
- Spinal surgery with epidural/intrathecal access 1
Urological Procedures - Variable Risk:
- TURP (transurethral resection of prostate): Associated with increased bleeding risk on aspirin; discontinuation recommended 1
- Percutaneous nephrolithotomy: Guidelines recommend discontinuation, though recent data suggests continuation may be safe in select patients 1, 3
- Radical prostatectomy and partial nephrectomy: Higher risk procedures where aspirin discontinuation is generally advised 1
- Prostate biopsy and ureteroscopy: Can be performed safely on low-dose aspirin 1
Rationale for 5-Day Washout in High-Risk Procedures
While 3 days of aspirin discontinuation improves platelet function in most patients, it does not achieve complete correction in all individuals. 1 Since high-bleeding risk procedures require complete correction of platelet function in 100% of patients (not just most), the 5-day washout provides the necessary safety margin. 1
Important Pharmacodynamic Considerations:
- Aspirin irreversibly inhibits thromboxane A2 synthesis 1
- Complete platelet turnover takes approximately 10 days, but full recovery is not necessary for hemostatic competence 1
- Interindividual variability means not all patients achieve complete correction after 4 days 1
- Certain populations may have accelerated platelet recovery (diabetics, high body weight, myeloproliferative disorders) 1
Procedures Where Aspirin Can Be Continued
For low and intermediate bleeding risk procedures, aspirin continuation is generally preferred, especially in patients with established cardiovascular disease or prior coronary stenting. 1
Continue Aspirin For:
- Most noncardiac, non-neurosurgical procedures in patients with coronary artery disease 1, 2
- Patients with coronary stents (especially within 12 months of drug-eluting stent placement) 1
- Dental procedures including tooth extraction 1
- Endoscopic procedures (though some Asian data suggests increased bleeding risk with certain procedures like endoscopic submucosal dissection) 4
Critical Timing Considerations for Patients with Coronary Stents
Elective surgery should NOT be performed within 30 days of bare-metal stent or within 6-12 months of drug-eluting stent if aspirin must be discontinued. 1 This represents a Class III (Harm) recommendation. 1
- For DES placed for acute coronary syndrome: delay surgery ≥12 months if aspirin interruption required 1
- For DES placed for stable CAD: delay surgery ≥6 months if aspirin interruption required 1
- Time-sensitive surgery may be considered ≥3 months after DES if surgical delay risk exceeds MACE risk 1
Common Pitfalls to Avoid
Do not use platelet function tests to guide aspirin discontinuation timing - the hemostatic safety threshold has not been established and test results are inconsistent 1
Do not assume 3 days is sufficient for high-risk procedures - while adequate for most procedures, high-bleeding risk surgery requires the 5-day washout 1
Do not routinely discontinue aspirin for primary prevention patients - these patients should stop aspirin preoperatively, especially with high bleeding risk 2, 5
Do not delay aspirin resumption - restart as soon as hemostasis is secure, ideally same day or within 24-72 hours postoperatively 1
For CABG specifically: While older recommendations suggested 7-10 day discontinuation 6, current evidence supports continuation in most patients to reduce MI risk, with increased transfusion risk being acceptable 1, 7